rs116257053

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198271.5(LMOD3):​c.1226A>G​(p.Gln409Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00246 in 1,613,846 control chromosomes in the GnomAD database, including 83 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 50 hom., cov: 31)
Exomes 𝑓: 0.0013 ( 33 hom. )

Consequence

LMOD3
NM_198271.5 missense

Scores

3
9
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 8.02

Publications

4 publications found
Variant links:
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
LMOD3 Gene-Disease associations (from GenCC):
  • nemaline myopathy 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006065905).
BP6
Variant 3-69119129-T-C is Benign according to our data. Variant chr3-69119129-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0133 (2028/152150) while in subpopulation AFR AF = 0.0451 (1871/41474). AF 95% confidence interval is 0.0434. There are 50 homozygotes in GnomAd4. There are 951 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 50 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LMOD3NM_198271.5 linkc.1226A>G p.Gln409Arg missense_variant Exon 2 of 3 ENST00000420581.7 NP_938012.2 Q0VAK6-1
LMOD3NM_001304418.3 linkc.1226A>G p.Gln409Arg missense_variant Exon 3 of 4 NP_001291347.1 Q0VAK6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LMOD3ENST00000420581.7 linkc.1226A>G p.Gln409Arg missense_variant Exon 2 of 3 1 NM_198271.5 ENSP00000414670.3 Q0VAK6-1
LMOD3ENST00000475434.1 linkc.1226A>G p.Gln409Arg missense_variant Exon 3 of 4 5 ENSP00000418645.1 Q0VAK6-1
LMOD3ENST00000489031.5 linkc.1226A>G p.Gln409Arg missense_variant Exon 3 of 4 2 ENSP00000417210.1 Q0VAK6-1

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
2023
AN:
152032
Hom.:
50
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0451
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00813
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00327
AC:
814
AN:
249112
AF XY:
0.00232
show subpopulations
Gnomad AFR exome
AF:
0.0472
Gnomad AMR exome
AF:
0.00200
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000620
Gnomad OTH exome
AF:
0.00116
GnomAD4 exome
AF:
0.00133
AC:
1946
AN:
1461696
Hom.:
33
Cov.:
33
AF XY:
0.00111
AC XY:
808
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.0479
AC:
1604
AN:
33480
American (AMR)
AF:
0.00246
AC:
110
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000270
AC:
30
AN:
1111856
Other (OTH)
AF:
0.00321
AC:
194
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
133
266
398
531
664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0133
AC:
2028
AN:
152150
Hom.:
50
Cov.:
31
AF XY:
0.0128
AC XY:
951
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0451
AC:
1871
AN:
41474
American (AMR)
AF:
0.00812
AC:
124
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68016
Other (OTH)
AF:
0.0118
AC:
25
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
98
196
295
393
491
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00426
Hom.:
47
Bravo
AF:
0.0158
ESP6500AA
AF:
0.0358
AC:
140
ESP6500EA
AF:
0.000121
AC:
1
ExAC
AF:
0.00399
AC:
482
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 15, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nemaline myopathy 10 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
T;T;T
Eigen
Pathogenic
0.76
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.77
.;.;T
MetaRNN
Benign
0.0061
T;T;T
MetaSVM
Uncertain
0.22
D
MutationAssessor
Uncertain
2.4
M;M;M
PhyloP100
8.0
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-2.6
D;D;D
REVEL
Uncertain
0.54
Sift
Uncertain
0.0010
D;D;D
Sift4G
Uncertain
0.0090
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.54
MVP
0.93
MPC
0.17
ClinPred
0.021
T
GERP RS
5.8
Varity_R
0.67
gMVP
0.51
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116257053; hg19: chr3-69168280; API